Cargando…
Dynamic changes of live/apoptotic circulating tumour cells as predictive marker of response to Sunitinib in metastatic renal cancer
BACKGROUND: Recently, we developed an apoptotic assay for expanding the monitoring capabilities of the circulating tumour cells (CTC) test during therapy. An automated platform for computing CTCs was integrated with a mAb (M30) targeting a neoepitope disclosed by caspase cleavage at cytokeratin 18 i...
Autores principales: | Rossi, E, Fassan, M, Aieta, M, Zilio, F, Celadin, R, Borin, M, Grassi, A, Troiani, L, Basso, U, Barile, C, Sava, T, Lanza, C, Miatello, L, Jirillo, A, Rugge, M, Indraccolo, S, Cristofanilli, M, Amadori, A, Zamarchi, R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3494437/ https://www.ncbi.nlm.nih.gov/pubmed/22955853 http://dx.doi.org/10.1038/bjc.2012.388 |
Ejemplares similares
-
Systemic immune-inflammation index predicts the clinical outcome in patients with metastatic renal cell cancer treated with sunitinib
por: Lolli, Cristian, et al.
Publicado: (2016) -
Silencing of miR-182 is associated with modulation of tumorigenesis through apoptosis induction in an experimental model of colorectal cancer
por: Perilli, Lisa, et al.
Publicado: (2019) -
Retaining the long-survive capacity of Circulating Tumor Cells (CTCs) followed by xeno-transplantation: not only from metastatic cancer of the breast but also of prostate cancer patients
por: Rossi, Elisabetta, et al.
Publicado: (2013) -
Allelic Imbalance Analysis in Liquid Biopsy to Monitor Locally Advanced Esophageal Cancer Patients During Treatment
por: Boldrin, Elisa, et al.
Publicado: (2020) -
Combining radiotherapy with sunitinib: lessons (to be) learned
por: Kleibeuker, Esther A., et al.
Publicado: (2015)